Literature DB >> 10810283

Differential effects of the charge variants of human follicle-stimulating hormone.

C M Timossi1, J Barrios-de-Tomasi, R González-Suárez, M C Arranz, V Padmanabhan, P M Conn, A Ulloa-Aguirre.   

Abstract

FSH is synthesized and secreted by the anterior pituitary gland in multiple molecular forms; the release of these isoforms depends on the endocrine status of the donor at the time of sample collection. In the present study, we analysed the possibility that the FSH charge isoforms may exert differential effects at the target cell. Seven FSH isoform mixes were isolated from pooled anterior pituitary glycoprotein extracts by high resolution chromatofocusing, followed by affinity chromatography, which removed nearly 90% of the LH that co-eluted with the FSH isoforms during chromatofocusing. The isoforms (isoform I, pH >7.10; II, pH range 6.60-6.20; III, pH 5. 47-5.10; IV, pH 5.03-4.60; V, pH 4.76-4.12; VI, pH 4.05-3.82 and VII, pH <3.80) were then tested for their capacity to stimulate cAMP release, androgen aromatization and tissue-type plasminogen activator (tPA) enzyme activity and cytochrome P450 aromatase, tPA and inhibin alpha-subunit mRNA production by rat granulosa cells in culture. cAMP and oestradiol production were determined by RIA, tPA enzyme activity by SDS-PAGE and zymography and all mRNAs by northern blot hybridization analysis and semiquantitative RT-PCR. All isoforms, with the exception of isoform I, stimulated synthesis and release of cAMP, oestrogen and tPA enzyme activity in a dose-dependent manner; the potency of the less acidic isoforms (pH 6. 60-4.60) was greater than that exhibited by the more acidic/sialylated analogs (pH 4.76 to <3.80; potencies II>III>IV>V>VII>VI). A similar trend was observed in terms of cytochrome P450 aromatase and tPA mRNA production. In contrast, when FSH-stimulated production of alpha-inhibin mRNA was analysed, isoforms V-VII were significantly more potent (two- to threefold) than the less acidic/sialylated counterparts (II-IV). In contrast to isoforms II-VII (which behaved as FSH agonists), isoform I (elution pH >7.10) completely blocked P450 aromatase and tPA mRNA expression, without altering that of a constitutively expressed gene (glyceraldehyde-3-phosphate dehydrogenase). These results show for the first time that the naturally occurring human FSH isoforms may exhibit differential or even unique effects at the target cell level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810283     DOI: 10.1677/joe.0.1650193

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

1.  A human FSHB transgene encoding the double N-glycosylation mutant (Asn(7Δ) Asn(24Δ)) FSHβ subunit fails to rescue Fshb null mice.

Authors:  Huizhen Wang; Vladimir Butnev; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-02-19       Impact factor: 4.102

Review 2.  Novel pathways in gonadotropin receptor signaling and biased agonism.

Authors:  Alfredo Ulloa-Aguirre; Pascale Crépieux; Anne Poupon; Marie-Christine Maurel; Eric Reiter
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 3.  Molecular regulation of follicle-stimulating hormone synthesis, secretion and action.

Authors:  Nandana Das; T Rajendra Kumar
Journal:  J Mol Endocrinol       Date:  2018-02-07       Impact factor: 5.098

4.  Evaluation of in vivo bioactivities of recombinant hypo- (FSH21/18) and fully- (FSH24) glycosylated human FSH glycoforms in Fshb null mice.

Authors:  Huizhen Wang; Jacob May; Viktor Butnev; Bin Shuai; Jeffrey V May; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-08-22       Impact factor: 4.102

5.  Hypo-glycosylated human follicle-stimulating hormone (hFSH(21/18)) is much more active in vitro than fully-glycosylated hFSH (hFSH(24)).

Authors:  George R Bousfield; Vladimir Y Butnev; Viktor Y Butnev; Yasuaki Hiromasa; David J Harvey; Jeffrey V May
Journal:  Mol Cell Endocrinol       Date:  2013-12-01       Impact factor: 4.102

Review 6.  Multiple facets of follicle-stimulating hormone receptor function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; Ana Ma Pasapera; Patricia Casas-González; James A Dias
Journal:  Endocrine       Date:  2008-02-02       Impact factor: 3.633

7.  Comparative pharmacology of a new recombinant FSH expressed by a human cell line.

Authors:  Wolfgang Koechling; Daniel Plaksin; Glenn E Croston; Janni V Jeppesen; Kirsten T Macklon; Claus Yding Andersen
Journal:  Endocr Connect       Date:  2017-04-27       Impact factor: 3.335

8.  The Common Follicle-Stimulating Hormone Receptor (FSHR) Promoter Polymorphism FSHR -29G > A Affects Androgen Production in Normal Human Small Antral Follicles.

Authors:  Tanni Borgbo; Hana Klučková; Milan Macek; Jana Chrudimska; Stine Gry Kristensen; Lise Lotte Hansen; Claus Yding Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-02       Impact factor: 5.555

9.  In Vitro Impact of FSH Glycosylation Variants on FSH Receptor-stimulated Signal Transduction and Functional Selectivity.

Authors:  Teresa Zariñán; Viktor Y Butnev; Rubén Gutiérrez-Sagal; José Luis Maravillas-Montero; Iván Martínez-Luis; Nancy R Mejía-Domínguez; Guillermo Juárez-Vega; George R Bousfield; Alfredo Ulloa-Aguirre
Journal:  J Endocr Soc       Date:  2020-02-18

10.  Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty.

Authors:  A Olivares; D Söderlund; C Castro-Fernández; T Zariñán; Elena Zambrano; J P Méndez; A Ulloa-Aguirre
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.